About Us

About Us

Our Commitment

We believe in the importance of your medical device. Our 20+ years of experience in Medtech gives us a deep understanding of the benefit it could bring to people’s lives.

From start to finish, our team is laser-focused with only one goal in mind: Navigating your company through all of its challenges towards a successful acquisition.

To get you there, we are committed to bringing you fast, cost-effective, high-quality, and ethical clinical data.

Our Commitment

Our Mission

Changing Local Economies

When we and our Medtech associates perform clinical studies in the countries we operate in, the impact on the local economy creates ripples with far-reaching benefits.

These include creating jobs, promoting economic growth, improving healthcare, increasing research and development, and gaining international recognition.

Our Commitment

Changing The World

Observing our mission from a bird’s eye view, it is ultimately about benefiting humanity as a whole. 

The work we do with our associates promotes international collaboration and transferring of knowledge, leading to better global health outcomes. Most importantly, it drives innovation in Medtech and the next generation of medical devices.

Our Commitment

Changing Lives

Revolutionizing lives in Latin America with early access to cutting-edge Medtech technologies, igniting hope and transforming the destinies of those in need and their loved ones.

Seeing the subjects we have recruited smile and be happy again thanks to successful medical device implants is a daily motivator for our team.

Our Story

Innovative Origins

bioaccess® began with Harvard-trained interventional cardiologist Dr. Pedro Martinez-Clark, an assistant professor at the University of Miami (UM). 

In 2008, Dr. Martinez-Clark, Dr. William O'Neill, Dr. Eduardo DeMarchena, and other physician-researchers at UM began collaborating with a research center in Colombia to evaluate the clinical validation of a new cardiac valve that Mitralign (a Boston-area Medtech company) was developing.

Our Story
Our Story

A Solution-Oriented Approach

Mitralign had been struggling to find a research site that could offer fast, cost-effective, and quality first-in-human (FIH) clinical data in the United States. Latin America provided the solution, checking positively on these three basis requirements.

Dr. Martinez-Clark knew that Mitralign wasn’t the only Medtech startup struggling with similar developmental challenges. He realized the bottleneck that was preventing these companies from advancing their medical devices could be addressed. 

The stage was set for creating a gateway that would provide solutions to their needs with the yet untapped potential that Latin America offered.

In 2010, Dr. Martinez-Clark started a contract research organization (CRO) called Interventional Concepts, dedicated to helping U.S based Medtech startups conduct clinical trials in Colombia. 

Advance Your Medical Device Sooner

In Pursuit of a Better Tomorrow

The company name was changed to bioaccess® in 2016, reflecting an expanded and specialized focus on pilot, first-in-human (FIH), early-feasibility (EFS), pivotal, and post-market clinical follow-up (PMCF) study services.

bioaccess® has since expanded its service capabilities and operations beyond Colombia to all of Latin America, further broadening its ability to meet the varied and unique clinical research needs of its Medtech associates.

To date, bioaccess® has overseen:

Our Story

Leadership Team

Julio Martinez-Clark

Pedro Martinez-Clark, MD, FACC

William O'Neill, MD, FACC, MSCAI

Monica Mora

John Myklush

Jesus Moreno

Leadership Team

Ana Criado

Oswaldo Amaya, MD

Katherine Ruiz

Sergio Alvarado, MD

Juan Cuya, MD

Advisory Board

Ron Zelhof

Michael Alvarez